In the News
Endocrine therapy, chemotherapy had similar efficacy in women with early-stage breast cancer and a midrange recurrence score
Rates of survival free of invasive disease were similar at nine years among women undergoing adjuvant endocrine therapy and chemotherapy, and the two groups had similar rates of freedom from distant disease recurrence, freedom from recurrence at a distant or local-regional site, and overall survival.
ABIM study finds MOC status associated with higher HEDIS process measures
Healthcare Effectiveness Data and Information Set (HEDIS) process measures were slightly higher among physicians pursuing Maintenance of Certification in five categories, but were still low overall in some of the areas.
MKSAP Quiz: Painless intermittent bloody urine
A 56-year-old man is evaluated for painless intermittent bloody urine of 6 weeks' duration. History is significant for granulomatosis with polyangiitis (formerly known as Wegener granulomatosis) diagnosed 10 years ago, which is now in remission; he was treated with prednisone for 3 years and oral cyclophosphamide for 1 year. Following a physical exam, lab studies, and chest radiograph, what is the most appropriate diagnostic test to perform next?
Long-term viral suppression may help decrease cancer rates in patients with HIV
The trend toward decreased incidence with increased suppression was strongest for AIDS-defining cancer, weaker for non-AIDS-defining cancer caused by viruses, and not present for non-AIDS-defining cancer not caused by viruses.
New ACP-Curbsiders podcast episode available, “Knee Pain: Practical Office Orthopedics”
Listen to get practical tips from orthopedist and medical educator Ted Parks, MD.
Governance Committee seeks Regent, Treasurer candidates for 2019
All candidates for Regent and Treasurer must declare their intent to become a candidate by Aug. 1, 2018.
Put words in our mouth
ACP Internist Weekly wants readers to create captions for our new cartoon and help choose the winner. Pen the winning caption and win a $50 gift certificate good toward any ACP product, program, or service.